Correction: Dekker, S.E.; Deng, L. Clinical Advances and Challenges in Targeting KRAS Mutations in Non-Small Cell Lung Cancer. Cancers 2024, 16, 3885

Dekker, Simone E.; Deng, Lei

doi:10.3390/cancers17010098

Open AccessCorrection

Correction: Dekker, S.E.; Deng, L. Clinical Advances and Challenges in Targeting KRAS Mutations in Non-Small Cell Lung Cancer. Cancers 2024, 16, 3885

by

Simone E. Dekker

^1,2 and

Lei Deng

^1,2,*

¹

Division of Hematology and Oncology, Department of Medicine, School of Medicine, University of Washington, Seattle, WA 98195, USA

²

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA

^*

Author to whom correspondence should be addressed.

Cancers 2025, 17(1), 98; https://doi.org/10.3390/cancers17010098

Submission received: 12 December 2024 / Accepted: 16 December 2024 / Published: 31 December 2024

(This article belongs to the Special Issue Advances in Precision Medicine: Targeting Known and Emerging Oncogenic Targets in Lung Cancer)

Download Versions Notes

Missing Conflicts of Interest

In the original publication [1], the Conflicts of Interest statement was missing. The Conflicts of Interest are included in this correction as follows:

Conflicts of Interest: L.D. declares the following conflicts of interest: Honoraria from MJH Life Sciences, Precisca; Consulting fees from Bristol-Myers Squibb, Regeneron; Travel from Merck, MJH Life Sciences; Institutional research funding from Bridgebio Oncology Therapeutics.

The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

Dekker, S.E.; Deng, L. Clinical Advances and Challenges in Targeting KRAS Mutations in Non-Small Cell Lung Cancer. Cancers 2024, 16, 3885. [Google Scholar] [CrossRef]

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Share and Cite

MDPI and ACS Style

Dekker, S.E.; Deng, L. Correction: Dekker, S.E.; Deng, L. Clinical Advances and Challenges in Targeting KRAS Mutations in Non-Small Cell Lung Cancer. Cancers 2024, 16, 3885. Cancers 2025, 17, 98. https://doi.org/10.3390/cancers17010098

AMA Style

Dekker SE, Deng L. Correction: Dekker, S.E.; Deng, L. Clinical Advances and Challenges in Targeting KRAS Mutations in Non-Small Cell Lung Cancer. Cancers 2024, 16, 3885. Cancers. 2025; 17(1):98. https://doi.org/10.3390/cancers17010098

Chicago/Turabian Style

Dekker, Simone E., and Lei Deng. 2025. "Correction: Dekker, S.E.; Deng, L. Clinical Advances and Challenges in Targeting KRAS Mutations in Non-Small Cell Lung Cancer. Cancers 2024, 16, 3885" Cancers 17, no. 1: 98. https://doi.org/10.3390/cancers17010098

APA Style

Dekker, S. E., & Deng, L. (2025). Correction: Dekker, S.E.; Deng, L. Clinical Advances and Challenges in Targeting KRAS Mutations in Non-Small Cell Lung Cancer. Cancers 2024, 16, 3885. Cancers, 17(1), 98. https://doi.org/10.3390/cancers17010098

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

Correction: Dekker, S.E.; Deng, L. Clinical Advances and Challenges in Targeting KRAS Mutations in Non-Small Cell Lung Cancer. Cancers 2024, 16, 3885

Missing Conflicts of Interest

Reference

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI